Fariborz Keyhanfar

No ORCID on file · 4 papers in corpus · active 2020-2022

Study types

  • other 3
  • article 1
other 2022
BioMed research international ·doi:10.1155/2022/1111777

Studies suggest that ovarian hyperstimulation syndrome (OHSS) can be treated by reducing the level of vascular endothelial growth factor (VEGF). However, due to the side effects of commercially available VEGF-reducing drugs, they can be rul…

other 2021
Canadian journal of physiology and pharmacology ·doi:10.1139/cjpp-2021-0094

Nanoparticles (NPs) have many toxic effects on fertility and can prevent successful implantation by affecting the maternal uterine tissue. Herein, by deploying 30 female NMRI mice, the effect of silver NPs on the endometrium and implantatio…

article 2020
·doi:10.1007/s40199-019-00310-2
other 2020
International journal of reproductive biomedicine ·doi:10.18502/ijrm.v13i10.7765

BACKGROUND: Many researchers consider implantation and endometrial receptivity as pertinent issues in reproductive science. Although, several experiments have been performed and their results evaluated, yet there is no confirmed evidence ab…